Sold under license to US Pat. 5,300,651 and EP 0 516 070. The use of this protected tryptophan derivative in Fmoc solid-phase peptide synthesis resulted in an improved yield of the correct product by suppressing side reactions of tryptophan.
Sold under license to US Pat. 5,300,651 and EP 0 516 070. The use of this protected tryptophan derivative in Fmoc solid-phase peptide synthesis resulted in an improved yield of the correct product by suppressing side reactions of tryptophan.
| Pack size available | 100g, 25g, 5g |
|---|
